ITTO20100146U1 - Dispositivo cilindrico per l'applicazione controllata di campi magnetici al corpo umano. - Google Patents
Dispositivo cilindrico per l'applicazione controllata di campi magnetici al corpo umano.Info
- Publication number
- ITTO20100146U1 ITTO20100146U1 ITTO20100146U ITTO20100146U1 IT TO20100146 U1 ITTO20100146 U1 IT TO20100146U1 IT TO20100146 U ITTO20100146 U IT TO20100146U IT TO20100146 U1 ITTO20100146 U1 IT TO20100146U1
- Authority
- IT
- Italy
- Prior art keywords
- magnetic
- cylindrical device
- cylindrical
- human body
- charge
- Prior art date
Links
- 230000005291 magnetic effect Effects 0.000 title claims description 49
- 230000009471 action Effects 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 6
- 238000009827 uniform distribution Methods 0.000 claims description 4
- 229910001369 Brass Inorganic materials 0.000 claims description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 3
- 229910052782 aluminium Inorganic materials 0.000 claims description 3
- 239000010951 brass Substances 0.000 claims description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052737 gold Inorganic materials 0.000 claims description 3
- 239000010931 gold Substances 0.000 claims description 3
- 230000005389 magnetism Effects 0.000 claims description 3
- 229920003023 plastic Polymers 0.000 claims description 3
- 229910052709 silver Inorganic materials 0.000 claims description 3
- 239000004332 silver Substances 0.000 claims description 3
- 229910052779 Neodymium Inorganic materials 0.000 claims description 2
- 239000000696 magnetic material Substances 0.000 claims description 2
- QEFYFXOXNSNQGX-UHFFFAOYSA-N neodymium atom Chemical compound [Nd] QEFYFXOXNSNQGX-UHFFFAOYSA-N 0.000 claims description 2
- 230000009977 dual effect Effects 0.000 claims 2
- 210000004027 cell Anatomy 0.000 description 9
- 239000004973 liquid crystal related substance Substances 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 208000000122 hyperventilation Diseases 0.000 description 2
- 230000000870 hyperventilation Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000036642 wellbeing Effects 0.000 description 2
- 206010006803 Burns third degree Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 230000035508 accumulation Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 230000016571 aggressive behavior Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 241000902900 cellular organisms Species 0.000 description 1
- 229910052729 chemical element Inorganic materials 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000005294 ferromagnetic effect Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 210000004884 grey matter Anatomy 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000003593 megakaryocyte Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/06—Magnetotherapy using magnetic fields produced by permanent magnets
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Magnetic Treatment Devices (AREA)
- Rehabilitation Tools (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITTO20100146 ITTO20100146U1 (it) | 2010-08-24 | 2010-08-24 | Dispositivo cilindrico per l'applicazione controllata di campi magnetici al corpo umano. |
| PCT/EP2011/003713 WO2012025180A1 (fr) | 2010-08-24 | 2011-07-22 | Dispositif cylindrique pour l'application maîtrisée de champs magnétiques au corps humain |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITTO20100146 ITTO20100146U1 (it) | 2010-08-24 | 2010-08-24 | Dispositivo cilindrico per l'applicazione controllata di campi magnetici al corpo umano. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ITTO20100146U1 true ITTO20100146U1 (it) | 2012-02-25 |
Family
ID=43739789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ITTO20100146 ITTO20100146U1 (it) | 2010-08-24 | 2010-08-24 | Dispositivo cilindrico per l'applicazione controllata di campi magnetici al corpo umano. |
Country Status (2)
| Country | Link |
|---|---|
| IT (1) | ITTO20100146U1 (fr) |
| WO (1) | WO2012025180A1 (fr) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1711875A1 (ru) * | 1988-08-18 | 1992-02-15 | Межотраслевой научно-технический комплекс "Микрохирургия глаза" | Способ лечени заболеваний зрительного тракта и устройство дл его осуществлени |
| US6648812B2 (en) * | 2001-02-28 | 2003-11-18 | Nu-Magnetics, Inc. | Bi-axial rotating magnetic therapeutic device |
| CA2526977A1 (fr) * | 2005-12-06 | 2006-04-20 | Kim Shallcross | Dispositif magnetique tournant fonctionnant au moyen d'une geometrie sacree |
| US20090198144A1 (en) * | 2007-09-25 | 2009-08-06 | Neosync, Inc. | Systems and Methods for Anxiety Treatment Using Neuro-EEG Synchronization Therapy |
| DE202009016847U1 (de) * | 2009-12-12 | 2010-03-11 | Kreikenbohm, Robert | Magnetfeldtherapiegerät mit einem Permanentmagneten |
-
2010
- 2010-08-24 IT ITTO20100146 patent/ITTO20100146U1/it unknown
-
2011
- 2011-07-22 WO PCT/EP2011/003713 patent/WO2012025180A1/fr active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012025180A1 (fr) | 2012-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zablotskii et al. | Effects of high-gradient magnetic fields on living cell machinery | |
| Goldsworthy et al. | Biological effects of physically conditioned water | |
| Becker et al. | Electromagnetism and life | |
| WO2021183209A2 (fr) | Procédés et dispositifs pour empêcher une transmission virale | |
| Glaser | Current concepts of the interaction of weak electromagnetic fields with cells | |
| CN104622104A (zh) | 一种局部磁场增强型保健床垫 | |
| ITTO20100146U1 (it) | Dispositivo cilindrico per l'applicazione controllata di campi magnetici al corpo umano. | |
| ITTO20090126U1 (it) | Dispositivo a medaglia per l'applicazione controllata di campi magnetici al corpo umano | |
| Karthick et al. | Review: Biological effects of magnetic fields on rodents | |
| Koziorowska et al. | The impact of electromagnetic fields with frequency of 50 Hz on metabolic activity of cells in vitro | |
| Sakhnini | Influence of Ca2+ in biological stimulating effects of AC magnetic fields on germination of bean seeds | |
| Zannella | Biological effects of magnetic fields | |
| Fukushima et al. | Milli Gauss pursed Magnetic Field Applied Phosphate Buffeted Saline Solution Elevates Intracellular Ca2+ Level and Stimulates Phagocytic Activity of Human Neutrophils | |
| Hernández-Hernández et al. | Neurite outgrowth on chromaffin cells applying extremely low frequency magnetic fields by permanent magnets | |
| Barnes | Interaction of direct current and extremely low-frequency electric fields with biological materials and systems | |
| JPS60259276A (ja) | 磁気治療用ベツド床 | |
| Zioni et al. | Strontium hexaferrite nanomagnets suspended in a cosmetic preparation: a convenient tool to evaluate the biological effects of surface magnetism on human skin | |
| Dempsey | Magnetism and biology | |
| İtegin et al. | Influence of Strong Static Magnetic Field on Bioelectrical Characteristics of Rat Hemidiaphragm Muscle | |
| Yu et al. | Static Magnetic Field Direction-Induced Differential Biological Effects | |
| TWI842030B (zh) | 小分子飲用水及其製備方法及應用 | |
| Santini et al. | A static magnetic field does not affect the dielectric properties of chick embryo myoblast membranes | |
| Shigemitsu et al. | The History of Bioelectromagnetism | |
| Rotariu et al. | The guidance of magnetic colloids in simulated tissues for targeted drug delivery | |
| DE29822541U1 (de) | Magnetische Gebäudebeläge zur Förderung der Gesundheit in Wohn-, Arbeits- und sonstigen Räumen |